Epilepsy in children
211 results
101 - 200
AAN guideline on withdrawing anticonvulsants in seizure-free adults and children
Lamotrigine add-on for drug-resistant partial epilepsy 
Lacosamide add‐on therapy for focal epilepsy- Carisbamate add‐on therapy for drug‐resistant focal epilepsy
- Psychological treatments for people with epilepsy
- Polyunsaturated fatty acid supplementation for drug-resistant epilepsy
- Vigabatrin add‐on therapy for drug‐resistant focal epilepsy
- Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
- Sleep disorders in children and adolescents
- Ketogenic diets for drug‐resistant epilepsy
- Rapid versus slow withdrawal of antiepileptic drugs
- Sulthiame add‐on therapy for epilepsy
- Lamotrigine add‐on therapy for drug‐resistant focal epilepsy
- Oxcarbazepine versus phenytoin monotherapy for epilepsy
- Clonazepam monotherapy for treating people with newly diagnosed epilepsy
- Cenobamate add‐on therapy for drug‐resistant focal epilepsy
- Vigabatrin versus carbamazepine monotherapy for epilepsy
- Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
- Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
- Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy
- Pregabalin monotherapy for epilepsy: Cochrane systematic review
- Perampanel add‐on for drug‐resistant focal epilepsy
- Treatment of a prolonged epileptic seizure and status epilepticus
- Gabapentin add‐on treatment for drug‐resistant focal epilepsy
- EEG for children with complex febrile seizures
- Stiripentol add‐on therapy for drug‐resistant focal epilepsy
- Similar rates of autism with lamotrigine, topiramate, and no treatment; rate with valproate is higher
- Vagus nerve stimulation for focal seizures
- Appointment with the family of a neurologically impaired and disabled child
- Brain and spinal cord tumours
- Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
- Little association between antibiotic use in pregnancy or early infancy and neurodevelopmental disorders in childhood
- Rufinamide add‐on therapy for drug‐resistant epilepsy
- Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
- Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review
- Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
- Melatonin as add‐on treatment for epilepsy
- Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
- Clobazam monotherapy for focal or generalized seizures
- Prognosis of adults and children following a first unprovoked seizure
- Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review
- Topiramate add‐on therapy for drug‐resistant focal epilepsy
- Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP)
- Antidepressants for people with epilepsy and depression
- Prognostic factors predicting an unprovoked seizure recurrence in children and adults following a first unprovoked seizure
- Febrile seizures
- Headache in children
- Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
- Combined vitamin B6‐magnesium treatment in autism spectrum disorder
- Paternal use of valproate is not associated with adverse outcomes among offspring
- Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy
- Clobazam add‐on therapy for drug‐resistant epilepsy
- Tiagabine add‐on therapy for drug‐resistant focal epilepsy
- Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
- Treating psychological problems in persons with intellectual disability (ID) in primary health care
- Antiepileptic drug monotherapy for epilepsy: a network meta‐analysis of individual participant data
- Phenytoin for neuropathic pain and fibromyalgia in adults
- Most children born prematurely survive to early- to mid-adulthood without major comorbidities
- Acute care of seizures of cerebral origin in children
- Clobazam monotherapy for partial-onset or generalized-onset seizures
- Treatment of infantile spasms
- ADHD
- Pharmacological treatment of depression
- Antiepileptic drugs for chronic non‐cancer pain in children and adolescents
- Involuntary movements
- Clinical criteria predict serious head injury risk in kids (CHALICE)
- Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review: Cochrane systematic review
- Speech and language therapy to improve the communication skills of children with cerebral palsy
- Conduct disorders in children and adolescents
- Anti‐seizure medications for neonates with seizures
- Intravenous immunoglobulin for the treatment of childhood encephalitis
- Osmotic therapies added to antibiotics for acute bacterial meningitis
- Drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children
- Anthelmintics for people with neurocysticercosis
- Down's syndrome
- Anti‐seizure medications for Lennox‐Gastaut syndrome
- Chloral hydrate as a sedating agent for neurodiagnostic procedures in children